The current status of multidrug-resistant tuberculosis in Korea

Tuberculosis and Respiratory Diseases

Volumn 60, Issue 4, 2006, Pages 404-411

  Kim, Byoung Ju ^a   Lee, In Hee ^a   Lee, Duk Hyung ^a   Bai, Gill Han ^b   Kong, Suk Jun ^c   Lee, Sun Hwa ^d   Moon, Hae Ran ^e   Lee, Kyoung Ryul ^f   Lee, Jun Young ^g   Park, Seung Kyu ^a,h  

^a National Mason Tuberculosis Hospital   (South Korea)

^b Korean Institute of Tuberculosis   (South Korea)

^c National Mokpo Tuberculosis Hospital   (South Korea)

^d NeoDin Medical Institute   (South Korea)

^e Green Cross Company   (South Korea)

^f Seoul Clinical Laboratories   (South Korea)

^g Seobuk Hospital   (South Korea)

^h National Masan TB Hospital   (South Korea)

Author keywords

Drug susceptibility test; Multidrug resistant tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL STUDY; DRUG BLOOD LEVEL; DRUG SENSITIVITY; FEMALE; HEALTH SURVEY; HUMAN; KOREA; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; TUBERCULOSIS;

EID: 33746440202     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.60.4.404     Document Type: Article

References (6)

1. Bai GH. Anti-tuberculosis drug resistance in Korea. CDMR 2005;16:101-7.
2. Korea Center for Disease Control and Prevention/Korean Institute of Tuberculosis. Tuberculosis notification report: 2004.1-2004.12. Seoul: KCDC/KIT; 2005.
3. Son CH, Yang DG, No MS, Jeong JS, Lee H, Lee GN, et al. Prevalence of drug-resistances in patients with pulmonary tuberculosis and its association with clinical characteristics at one tertiary referral hospital in Pusan, Korea. Tuberc Respir Dis 2001;51:416-25.
4. Kim JH, Kim JH, Jang TW, Jung MH. Drug-resistant pulmonary tuberculosis in Kosin Medical Center. Tuberc Respir Dis 1995;42:831-7.
5. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world report: third global report. Geneva: WHO; 2004.
6. Koh WJ, Kwon QJ, Kim CH, Ahn YM, Lim SY, Yun JU, et al. Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis at a private general hospital. Tuberc Respir Lung Dis 2003;55:154-64.